Bladder drug may save kids from second surgery for kidney stones
NCT ID NCT07617896
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if a drug called aminophylline, placed directly into the bladder, can help doctors insert a small scope to remove kidney stones in children. About 60 children aged 2 to 17 with a stone in the lower ureter will take part. If the first gentle attempt to pass the scope fails, the child will receive either the drug or a placebo. The goal is to see if the drug makes the second attempt successful, avoiding the need for balloon dilation or a second surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISTAL URETERAL STONE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Urology- Beni-Suef University Hospitals
RECRUITINGBanī Suwayf, Beni Suweif Governorate, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a softer stent spare kids from bladder spasms?
- New flexible suction sheath may improve kidney stone removal in children
- World's largest kidney stone surgery study launches
- Can an amino acid help pass kidney stones better than a standard drug?
- New stent aims to make kidney stone recovery less painful
- Laser showdown: which bladder stone removal technique is best for kids?